000290493 001__ 290493
000290493 005__ 20241031135002.0
000290493 0247_ $$2doi$$a10.3390/healthcare12100991
000290493 0247_ $$2pmid$$apmid:38786402
000290493 0247_ $$2pmc$$apmc:PMC11121431
000290493 037__ $$aDKFZ-2024-01120
000290493 041__ $$aEnglish
000290493 082__ $$a610
000290493 1001_ $$0P:(DE-He78)79897f8897ff77676549d9895258a0f2$$aRadtke, Jan Philipp$$b0$$eFirst author$$udkfz
000290493 245__ $$aValue-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a Balanced Score Card.
000290493 260__ $$aBasel$$bMDPI$$c2024
000290493 3367_ $$2DRIVER$$aarticle
000290493 3367_ $$2DataCite$$aOutput Types/Journal article
000290493 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1716806445_24791
000290493 3367_ $$2BibTeX$$aARTICLE
000290493 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000290493 3367_ $$00$$2EndNote$$aJournal Article
000290493 500__ $$a#EA:E010#
000290493 520__ $$aProstate cancer (PC) is the most common cancer in men in 112 countries, and accounts for 15% of cancers. Because it cannot be prevented, the rise in cases is inevitable, and improvements in diagnostic pathways and treatments are needed, as there is still a shortage of cost-effective diagnostics and widespread oncologically safe treatment options with measurable quality. As part of the implementation of a Full Cycle of Care, instruments have been developed to achieve value-based medicine, such as consistent commitment to measurability. One of these instruments is the Balanced Scorecard (BSC). Here, we propose the first BSC for prostate cancer (PC) treatment.BSCs are used to assess performance in healthcare organizations across four dimensions: financial, patient and referrer, process, and learning and development. This study aimed to identify Key Performance Indicators (KPIs) for each perspective. A systematic literature search was conducted according to PRISMA guidelines using multiple databases and specific search terms to identify KPIs for PC care, excluding case reports and conference abstracts. In total, 44 reports were included in analyses and development of the PC-specific BSC.In the present study, a PC-specific BSC and KPIs were defined for the four classic perspectives, as well as for a newly developed PC-Specific Disease and Outcome perspective, including patient-related parameters from the German Cancer Society and the International Consortium for Health Outcomes Measurement. In addition, the Process perspective includes KPIs of fulfillment of continuing education of residents and the metrics of structured training of the radical prostatectomy procedure in the Learning and Development perspective.The developed BSC provides a comprehensive set of perspectives for an Integrated Practice Unit or center in PC care, ensuring that the indicators remain manageable and applicable. The BSC facilitates value creation in line with Porter's Full Cycle of Care by systematically collecting and providing economic, personnel, and medical results, actions, and indicators. In particular, this BSC includes KPIs of structured training of practitioners and metrics of the German Cancer Society, that recently proved to improve PC patients outcomes.
000290493 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000290493 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000290493 650_7 $$2Other$$aBalanced Scorecard
000290493 650_7 $$2Other$$aICHOM
000290493 650_7 $$2Other$$ametrics
000290493 650_7 $$2Other$$aprostate cancer
000290493 650_7 $$2Other$$astandardized quality measurements
000290493 650_7 $$2Other$$avalue-based healthcare
000290493 7001_ $$0P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aAlbers, Peter$$b1$$udkfz
000290493 7001_ $$0P:(DE-HGF)0$$aHadaschik, Boris A$$b2
000290493 7001_ $$aGraefen, Markus$$b3
000290493 7001_ $$aMeyer, Christian P$$b4
000290493 7001_ $$aBehr, Björn$$b5
000290493 7001_ $$aNüesch, Stephan$$b6
000290493 773__ $$0PERI:(DE-600)2721009-1$$a10.3390/healthcare12100991$$gVol. 12, no. 10, p. 991 -$$n10$$p991$$tHealthcare$$v12$$x2227-9032$$y2024
000290493 8564_ $$uhttps://inrepo02.dkfz.de/record/290493/files/healthcare-12-00991.pdf
000290493 8564_ $$uhttps://inrepo02.dkfz.de/record/290493/files/healthcare-12-00991.pdf?subformat=pdfa$$xpdfa
000290493 909CO $$ooai:inrepo02.dkfz.de:290493$$pVDB
000290493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)79897f8897ff77676549d9895258a0f2$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000290493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f84639cbc39bc20ecda8d00e6de97578$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000290493 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000290493 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000290493 9141_ $$y2024
000290493 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bHEALTHCARE-BASEL : 2022$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T14:59:12Z
000290493 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T14:59:12Z
000290493 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-04-12T14:59:12Z
000290493 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2023-04-12T14:59:12Z
000290493 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)1180$$2StatID$$aDBCoverage$$bCurrent Contents - Social and Behavioral Sciences$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0130$$2StatID$$aDBCoverage$$bSocial Sciences Citation Index$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2023-08-28
000290493 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2023-08-28
000290493 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000290493 9201_ $$0I:(DE-He78)C130-20160331$$kC130$$lPersonalisierte Früherkennung des Prostatakarzinoms$$x1
000290493 9201_ $$0I:(DE-He78)ED01-20160331$$kED01$$lDKTK Koordinierungsstelle Essen/Düsseldorf$$x2
000290493 9200_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000290493 980__ $$ajournal
000290493 980__ $$aVDB
000290493 980__ $$aI:(DE-He78)E010-20160331
000290493 980__ $$aI:(DE-He78)C130-20160331
000290493 980__ $$aI:(DE-He78)ED01-20160331
000290493 980__ $$aUNRESTRICTED